Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy J Keding

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2004
Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumorsStacy J Keding, Samuel J Danishefsky
Immunology and Cell Biology|July 22, 2005
Carbohydrate vaccines as immunotherapy for cancerSusan F Slovin, Stacy J Keding, Govind Ragupathi
Current Topics in Medicinal Chemistry|November 11, 2008
Recent progress in the development of selective TRPV1 antagonists for painLisa M Broad, Stacy J Keding, Maria-Jesus Blanco
Journal of the American Chemical Society|May 27, 2004
Toward fully synthetic glycoproteins by ultimately convergent routes: a solution to a long-standing problemJ David Warren, Justin S Miller, Stacy J Keding, et al.
Journal of the American Chemical Society|February 24, 2006
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidatesGovind Ragupathi, Fusataka Koide, Philip O Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyaninLee M Krug, Govind Ragupathi, Chandra Hood, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2004
Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumorsStacy J Keding, Samuel J Danishefsky
Immunology and Cell Biology|July 22, 2005
Carbohydrate vaccines as immunotherapy for cancerSusan F Slovin, Stacy J Keding, Govind Ragupathi
Current Topics in Medicinal Chemistry|November 11, 2008
Recent progress in the development of selective TRPV1 antagonists for painLisa M Broad, Stacy J Keding, Maria-Jesus Blanco
Journal of the American Chemical Society|May 27, 2004
Toward fully synthetic glycoproteins by ultimately convergent routes: a solution to a long-standing problemJ David Warren, Justin S Miller, Stacy J Keding, et al.
Journal of the American Chemical Society|February 24, 2006
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidatesGovind Ragupathi, Fusataka Koide, Philip O Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyaninLee M Krug, Govind Ragupathi, Chandra Hood, et al.
Pageof 1